Rating Change
Cantor Fitzgerald reiterated its Overweight rating on Core Scientific, Inc. (NASDAQ:CORZ) on October 14, 2026.
reiterateNASDAQ:CORZ
Cantor Fitzgerald Reiterates Overweight Rating on Core Scientific, Inc. (CORZ)
Cantor Fitzgerald reiterated its Overweight rating on Core Scientific, Inc. (NASDAQ:CORZ) on October 14, 2026.
At publication ·
What changed
Core Scientific, Inc. (NASDAQ:CORZ) · reiterate
- Firm
- Cantor Fitzgerald
- Rating
- Overweight to Overweight
- Price at event
- $13.51
- Market capitalization
- $5.4B
At a glance
Key takeaways
- Core Scientific (CORZ) trades at $13.51 with a $5.4B market cap and has declined 16.7% over the past 52 weeks.
Market Context
Core Scientific, Inc. operates in the Technology sector. The stock currently trades at $13.51 with a market capitalization of $5.4B. The stock has declined 16.7% over the past 52 weeks.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Core Scientific, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Core Scientific, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Sep 23, 2026 | UBS | Buy | N/A |
| Sep 21, 2026 | Rothschild & Co | Neutral | N/A |
| Sep 17, 2026 | Wells Fargo | Overweight | N/A |
| Aug 03, 2026 | B. Riley Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CORZ Stock Page
Frequently Asked Questions
What does the Overweight rating mean for CORZ?
A rating of Overweight from Cantor Fitzgerald reflects the analyst's outlook on Core Scientific, Inc. (NASDAQ:CORZ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CORZ forecast page.